Estimating age-specific vaccine effectiveness using data from a large measles outbreak in Berlin, Germany, 2014/15: evidence for waning immunity

BACKGROUND: Measles elimination is based on 95% coverage with two doses of a measles-containing vaccine (MCV2), high vaccine effectiveness (VE) and life-long vaccine-induced immunity. Longitudinal analysis of antibody titres suggests existence of waning immunity, but the relevance at the population-...

Descripción completa

Detalles Bibliográficos
Autores principales: Bitzegeio, Julia, Majowicz, Shannon, Matysiak-Klose, Dorothea, Sagebiel, Daniel, Werber, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628761/
https://www.ncbi.nlm.nih.gov/pubmed/31039834
http://dx.doi.org/10.2807/1560-7917.ES.2019.24.17.1800529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628761/
https://www.ncbi.nlm.nih.gov/pubmed/31039834
http://dx.doi.org/10.2807/1560-7917.ES.2019.24.17.1800529

Ejemplares similares